Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Hanover Radiation Oncology is a specialized clinical healthcare provider based in Wilmington, North Carolina, that focuses on advanced radiation therapy for cancer patients. Now integrated into the Novant Health Cancer Institute, the center provides a comprehensive range of treatments including Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), and stereotactic radiosurgery. The facility utilizes state-of-the-art linear accelerators to deliver precise radiation doses for various malignancies such as breast, lung, and prostate cancers. As a key component of the regional oncology infrastructure, the practice emphasizes a multidisciplinary approach to patient care, collaborating with surgical and medical oncology teams to optimize clinical outcomes. It serves as a primary hub for radiation oncology services in the Cape Fear region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Hanover Radiation Oncology.